JPRN-UMIN000040283已完成未知
Prospective observational study evaluating amino acid dynamics during continuous renal replacement therapy - Amino acid dynamics in patients receive continuous hemofiltration
Department of Intensive Care Medicine, Sapporo Medical University School of Medicine0 个研究点目标入组 20 人开始时间: 2020年5月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with liver failure (2) Patients who need other blood purification therapy within 4 hours after the continuous hemofiltration is started (3) Patients who need to change the conditions of continuous hemofiltration within 4 hours after the continuous hemofiltration is started (4) Patients who need enteral nutrition or parenteral nutrition containing amino acids within 4 hours after the continuous hemofiltration is started (5) Patients who are determined ineligible by the principal investigator
研究者
相似试验
已完成
Unknown
Prospective Observational Study on the Ameliorating Effects of Imeglimin on Blood Glucose Spikes and Vascular Endothelial FunctioDiabetesJPRN-UMIN000046311Faculty of Medicine, University of Miyazaki13
招募中
Unknown
An observational, prospective study to assess the efficacy and safety of Adalloce in patients with Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS)Diseases of the musculoskeletal system and connective tissueKCT0009141Yuhan1,000
招募中
1 期
A Studypain relief and assess recovery using intravenous Lignocaine in Laparoscopic Surgeries.CTRI/2020/07/026750ita Dsouza
已完成
不适用
Prospective observational study of the treatment and prognosis in patients with relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.Adult T-cell leukemia-lymphomaJPRN-UMIN000009251JSCT30
招募中
不适用
Prospective observational study of the treatment and prognosis in patients with previously untreated indolent B cell lymphomaIndolent B-cell Non-Hodgkin's lymphomaJPRN-UMIN000010175Fukuoka Lymphoma Study Group200
